Association between pharmacokinetics of oral ibandronate and clinical response in bone mass and bone turnover in women with postmenopausal osteoporosis-Reference-Cited by-同舟云学术

Association between pharmacokinetics of oral ibandronate and clinical response in bone mass and bone turnover in women with postmenopausal osteoporosis

Published:2002-01 Issue:1 Volume:30 Page:320-324
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Ravn P,Neugebauer G,Christiansen C

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference27 articles.

1. Bauss, F., Lalla, R., Endele, R., and Hothorn, L. H. The effects of treatment with ibandronate on bone mass, architecture, biomechanical properties and bone concentration in ovariectomized aged rats. Osteoporos Int in press.

2. Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women;Bjarnason;Bone,2000

3. Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases;Boissier;Cancer Res,2000

4. Immunoassay for quantifying type I collagen degradation products in urine evaluated;Bonde;Clin Chem,1994

5. Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides;Christgau;Clin Chem,1998

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zoledronic Acid-Loaded β-TCP Inhibits Tumor Proliferation and Osteoclast Activation: Development of a Functional Bone Substitute for an Efficient Osteosarcoma Treatment;International Journal of Molecular Sciences;2021-02-14

2. Development and application of a urine drug concentration method for the evaluation of oral absorption of ibandronate in clinical patients;Bioanalysis;2019-07

3. Ibandronate☆;Reference Module in Biomedical Sciences;2017

4. Systematic review of the use of bone turnover markers for monitoring the response to osteoporosis treatment: the secondary prevention of fractures, and primary prevention of fractures in high-risk groups;Health Technology Assessment;2014-02

5. In Vitro and In Vivo Responses to High and Low Doses of Nitrogen-Containing Bisphosphonates Suggest Engagement of Different Mechanisms for Inhibition of Osteoclastic Bone Resorption;Calcified Tissue International;2013-02-24